Testing effectiveness (Phase 2)Ended earlyNCT06317285
What this trial is testing
Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 158